Quarterly Results • Search Archive
Alivus Life Sciences Limited
Results, Financials & Updates
Follow Alivus Life Sciences Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
1 published deep dive
1 quarter 1 sector
Company Overview
Alivus Life Sciences Limited: latest results and financials
About the business in Nivata's latest coverage
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) is a developer and manufacturer of select, high-value, non-commoditized Active Pharmaceutical Ingredients (APIs) focusing on chronic therapeutic areas such as cardiovascular disease, central nervous system disease, pain management, and diabetes. The company also provides Contract Development and Manufacturing Organization (CDMO) services to multinational and specialty pharmaceutical companies across global markets.
Quarter history
Alivus Life Sciences Limited Results & Financials
Latest Nivata coverage: Q1 FY27 · revenue ₹640.41 Cr · PAT ₹160.08 Cr.
Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.